Physician Assistant Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Matthew Elliott

Gastroenterology Palm Springs, CA Physician Assistant

NPI 1497244792 CMS profile 4398763

1330 N Indian Canyon Dr, Palm Springs, CA 92262

Open in the dashboard

General payments

$3,075

159 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Matthew Elliott of Palm Springs, CA is reported in the CMS Open Payments database as having received $3,075 across 159 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 56th percentile of Gastroenterology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,442 74
2024 General $866 47
2023 General $172 8
2022 General $286 14
2021 General $309 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Matthew Elliott
  • Gastroenterology median
  • Middle half of Gastroenterology
  • National median

In program year 2025, general payments to Matthew Elliott were reported at $1,442. Among 13,050 Gastroenterology profiles paid that year, the median was $639 and the middle half received between $167 and $1,700.

Show as a table
Year Matthew Elliott Gastroenterology median Middle half National median
2019 $0 $417 $126–$1,100 $163
2020 $0 $224 $74–$624 $114
2021 $309 $352 $106–$1,054 $132
2022 $286 $448 $129–$1,270 $149
2023 $172 $533 $150–$1,390 $160
2024 $866 $605 $160–$1,606 $164
2025 $1,442 $639 $167–$1,700 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $616 47 payments
  2. Madrigal Pharmaceuticals $458 15 payments
  3. Janssen Biotech, Inc. $265 14 payments
  4. Ipsen Biopharmaceuticals, Inc $180 8 payments
  5. Merck Sharp & Dohme Corporation $172 9 payments
  6. Intercept Pharmaceuticals, Inc. $168 8 payments
  7. RedHill Biopharma Inc. $154 9 payments
  8. Genzyme Corporation $132 4 payments
  9. Regeneron Healthcare Solutions, Inc. $127 6 payments
  10. Salix Pharmaceuticals, a division of Bausch Health US, LLC $124 7 payments
  11. Other $679 32 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $3,075 159 payments
Products named General payments · program years 2021–2025
  1. REZDIFFRA $347 12 payments
  2. RINVOQ $259 22 payments
  3. MAVYRET $238 12 payments
  4. STELARA $187 8 payments
  5. TREMFYA $184 11 payments
  6. IQIRVO $180 8 payments
  7. DIFICID $172 9 payments
  8. SKYRIZI $155 13 payments
  9. Talicia $154 9 payments
  10. OCALIVA $146 7 payments
  11. Other $1,802 99 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

737

Median for Physician Assistant: 241

Drug cost

$105,192

Median for Physician Assistant: $4,110

Branded share of claims

14.1%

Median for Physician Assistant: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Creon Lipase/Protease/Amylase Brand 15 $41,650
Linzess Linaclotide Brand 38 $31,893
Mesalamine Generic 31 $8,820
Pentasa Mesalamine Brand 13 $6,129
Omeprazole Generic 300 $5,293
Ursodiol Generic 19 $3,871
Sucralfate Generic 25 $2,321
Pantoprazole Sodium Generic 194 $2,266
Cholestyramine Cholestyramine (With Sugar) Brand 38 $2,051
Famotidine Generic 37 $598

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 114,276 Part D prescribers listed as Physician Assistant; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 4 billing codes

Paid by Medicare

$14,151

Medicare's payments for the services billed

Medicare patients

145

Average age 69

Services billed

230

79 women, 66 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 51%
Diabetes 40%
Chronic kidney disease 34%
Depression 26%
Ischemic heart disease 22%
COPD 19%
Osteoporosis 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 21 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
RESMETIROM
  • Madrigal Pharmaceuticals $111
$111 — —
DIFICID
  • Merck Sharp & Dohme Corporation $96
$96 — —
DUPIXENT
  • Regeneron Healthcare Solutions, Inc. $38
  • GENZYME CORPORATION $34
$72 — —
RINVOQ
  • AbbVie, Inc. $65
$65 — —
SKYRIZI
  • AbbVie, Inc. $65
$65 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 21 in the dashboard with a free account

Records

159 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gastroenterology in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record